Conference Correspondent  - Conference Correspondent, ASH
Beth Faiman, PhD, APRN-BC, AOCN
Founding Editor in Chief

Beth Faiman argues that patient support services are integral in her role as a nurse because they aid in getting patients the treatments they need, promote adherence, and provide patient education.

Patient support services are really important to our patients with multiple myeloma. I all ready mentioned that when you have the right drug for the right patient, one of the challenges is actually getting that drug to the patient, and having them understand how to take it. This is a specific concern with the oral oncolytics, because the high copays that might be involved, et cetera.

The patient support services are really intrical because there are people within each pharmacy and each pharma company that are dedicated to help get the drugs to the patients that need them.

I think that that helps me as a nurse in the clinic so much to have those resources for our patients. Not only getting the drugs there, but providing education, helping with adherence and facilitating refills. These are all very important to the improved care of our patients.

Related Items
Polatuzumab Vedotin plus R-CHP Outperforms Standard of Care in Treatment of DLBCL
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in ASH, Lymphoma
Time-Limited Venetoclax-Based Regimens Demonstrate Promising Efficacy in Fit Patients with CLL
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in ASH
Mosunetuzumab Induces Deep Remissions in Patients with Relapsed/Refractory Follicular Lymphoma
William King
TOP - January 2022 Vol 15, No 1 – Online Only published on January 20, 2022 in ASH
Results from 2 Studies Provide Insights on Antibody Response to COVID-19 Vaccines in Patients with Hematologic Malignancies
William King
TOP - January 2022 Vol 15, No 1 – Online Only published on January 20, 2022 in ASH
CAR T-Cell Therapies Show Efficacy in Second-Line Treatment of Large B-Cell Lymphoma
William King
TOP - January 2022 Vol 15, No 1 – Online Only published on January 20, 2022 in ASH
No Link between Long-Term Eltrombopag Treatment and Incidence of Cataracts in Adult Patients with Chronic ITP During EXTEND
Conference Correspondent  published on December 27, 2017 in ASH
Eltrombopag Treatment Improved Platelet Counts in Patients with Persistent or Chronic ITP
Conference Correspondent  published on December 27, 2017 in ASH
Fostamatinib-Treated Patients with Persistent/Chronic ITP Maintained Long-Term Responses
Conference Correspondent  published on December 27, 2017 in ASH
Avatrombopag Superior to Placebo for the Treatment of Chronic ITP
Conference Correspondent  published on December 27, 2017 in ASH
Subcutaneous Romiplostim Increased Platelet Response in Children with ITP
Conference Correspondent  published on December 27, 2017 in ASH
Last modified: July 22, 2021